Latest Asx Healthcare Stocks News

Page 1 of 1

InhaleRx Accelerates IRX-211 Trial with Rapid HREC Approval and Expanded Scope

InhaleRx has secured swift Human Research Ethics Committee approval for its redesigned IRX-211 Phase 2 trial, expanding participant numbers and potentially bypassing Phase 3 to speed market entry.

Ada Torres

3 June 2025

Top